National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH conjugate vaccine
A heptavalent vaccine consisting of the tumor-associated carbohydrate antigens globohexaosylceramide (globo-H), GM2, Lewis-y, MUC1-32(aa), sTn(c), TF(c), and Tn(c) conjugated with keyhole limpet hemocyanin (KLH), an immunomodulator. This vaccine may induce the production of IgG and IgM antibodies and an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumors expressing these antigens. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:GLO-GM2-LE-MUC1-sTN-TF-TN-KLH



Previous:ginger extract, Girostan, Gleevec, Gliadel wafer, glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine
Next:glucarpidase, Glucophage, glucosamine sulfate/chondroitin sulfate tablet, glutamine, glutathione disulfide NOV-002

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov